One of Stepes’ clinical study translation offerings is back translation. To ensure the utmost accuracy and regulatory compliance, certain clinical study documents, such as informed consent forms and clinical outcome assessments, may require back-translation services. This process involves translating the localized document back into the source language by a different translator and comparing it with the original to ensure accuracy and consistency. Stepes provides professional back translations regularly as part of our clinical study translation solutions. To learn more, please click here.

Numerous pharmaceutical, biotechnology, and CRO organizations, such as Pfizer, Novartis, Sanofi, Amgen, Merck, and AstraZeneca, conduct clinical trials worldwide to support their clinical research and development operations. Stepes is a leading provider of professional clinical trial translation services between English and European, Asian, and Latin American languages, utilizing state-of-the-art machine-human solutions to ensure high-quality, rapid turnaround, and cost-effective clinical study translation services. As an ISO 9001 and ISO 13485-certified translation company, we possess the necessary expertise, resources, and quality management systems to deliver accurate and compliant translations for the global clinical research community. To learn more, please click here.